Ledger.Open graph →
SEC Form D · Amendment · filed August 13, 2018

Aclaris Therapeutics, Inc

Offering
$12.5M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WAYNE, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Benjamin S. Miller · WASHINGTON, Washington, D.C.DirectorChristopher Powala · Wayne, PAExecMatt Auriemma · Grand Cayman, Cayman IslandsDirectorAndrew A. Schiff · Wayne, PADirectorFrank Ruffo · MALVERN, PAExecAnand A. Mehra · Malvern, PADirectorBrett A. Fair · Wayne, PAExecBryan A. Reasons · Wayne, PADirectorAndrew A. Powell · Wayne, PADirectorChristopher A. Molineaux · Malvern, PADirectorWilliam A. Humphries · Wayne, PADirectorKamil Ali-Jackson · Malvern, PAExecNeal Walker · Wayne, PAExec · DirectorChristopher Powala · MALVERN, PAExecStuart Shanler · MALVERN, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗